Now showing items 81-90 of 105
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
(Biomed Central, 2010)
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compared to men but have limited options to reduce their HIV risk. Microbicides could fill an important HIV prevention gap ...
Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.
(Oxford University Press for the International Epidemiological Association., 2010)
Objective: To determine the HIV incidence rate among rural and urban women in KwaZulu-Natal, South Africa. Methods: We conducted a prospective cohort study from March 2004 to May 2007. Volunteers were recruited from a ...
HIV incidence in young girls in KwaZulu-Natal, South Africa - public health imperative for their inclusion in HIV biomedical intervention trials.
(Springer U.S., 2012)
Young women are particularly vulnerable for acquiring HIV yet they are often excluded from clinical trials testing new biomedical intervention. We assessed the HIV incidence and feasibility of enrolling a cohort of young ...
HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services.
(BioMed Central., 2011)
Background: Young girls in sub Saharan Africa are reported to have higher rates of human immunodeficiency virus (HIV) infection compared to boys in the same age group. Knowledge of HIV status amongst high schools learners ...
Screening for ‘window-period’ acute HIV infection among pregnant women in rural South Africa.
(Wiley-Blackwell for British HIV Association., 2010)
Objectives. The aim of this study was to evaluate the HIV-1 RNA pooled nucleic acid amplification testing (NAAT) strategy to screen pregnant women in the ‘window period’ of acute HIV infection (AHI) in rural South ...
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.
Abstract available in PDF file.
Genital inflammation and the risk of HIV acquisition in women.
(Oxford University Press., 2015)
Abstract available in pdf.
Genital—systemic chemokine gradients and the risk of HIV acquisition in women.
(Wolters Kluwer Health., 2017)
Abstract available in pdf.
Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial.
Abstract not available in pdf.
Initiating antiretrovirals during tuberculosis treatment: a drug safety review.
(Informa UK, Ltd., 2011)
Introduction: Integrating HIV and tuberculosis (TB) treatment can reduce mortality substantially. Practical barriers to treatment integration still exist and include safety concerns related to concomitant drug use because ...